MedPath

Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different Stages

Not Applicable
Completed
Conditions
Bell's Palsy
Registration Number
NCT00608660
Lead Sponsor
Chengdu University of Traditional Chinese Medicine
Brief Summary

The purpose of this trial will certify the efficacy of using staging acupuncture and moxibustion to treat Bell's Palsy

Detailed Description

The result of this trial (available in 2009) aims to testify the efficacy of using staging acupuncture and moxibustion to treat Bell's Palsy, and to approach a best acupuncture treatment among these five different methods for treating Bell's Palsy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
900
Inclusion Criteria
  • patients who meet the diagnosis, stages, location criteria
  • the first time to onset the disease
  • between 1 and 70 days with the onset time of facial palsy
  • on one side of the face paralysis
  • between 15 and 70 years old with the onset age of facial palsy
  • willing to finish the whole observation period
  • with written consent form signed by themselves.
Exclusion Criteria
  • facial palsy caused by other disease, such as infectivity multiple radiculitis, tumor which offend temporal bone, cerebral trauma
  • facial palsy combine diabetes, the severe disease of heart vessel, cerebral vessel, liver, kidney, lung, and psychosis
  • patient with Hunt's syndrome
  • patient with facial spasm
  • pregnant women or women in lactation
  • patients are participating other clinical research

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
House-Brackmann scale (Global Score)a week
Secondary Outcome Measures
NameTimeMethod
WHOQOL-BREF scaletwo week
Classification Score Of Facial Paralysis Degreea week
Facial Disability Indexa week
House-Brackmann scale (Regional Score)a week

Trial Locations

Locations (1)

Chengdu university of TCM

🇨🇳

Chengdu, Sichuan, China

Chengdu university of TCM
🇨🇳Chengdu, Sichuan, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.